RS

Ranjit Sing

Director DIN 08265098
DIN 08265098 First appointment Oct 2018
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Ranjit Sing

Data last updated:

Ranjit Sing was a Director at Raninder Enterprises Private Limited (from 2019) and Additional Director at Kzone Healthcare Private Limited (from 2018).

DIN 08265098
First Appointment 22 Oct 2018
Oldest Company Age 11 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Raninder Enterprises Private Limited U74999DL2019PTC345327
Director31 Jan 20192019Strike Off
Kzone Healthcare Private Limited U85100DL2015PTC281294
Additional Director22 Oct 20182015₹34.8 Lakh (FY 2016)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Raninder Enterprises Private Limited
Kzone Healthcare Private Limited
Premium access

Shareholding and investment profile for Ranjit Sing

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjit Sing

Ranjit Sing was first appointed on 22 Oct 2018 as Additional Director at Kzone Healthcare Private Limited. The most recent appointment on record is 31 Jan 2019 at Raninder Enterprises Private Limited.

Ranjit Sing held 2 earlier board appointments: Raninder Enterprises Private Limited (Director, from 31 Jan 2019); Kzone Healthcare Private Limited (Additional Director, from 22 Oct 2018).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available